FDA approves selegiline transdermal for the treatment of major depressive disorder in adults

被引：0

|

作者：

Naccari, C

机构：

来源：

CNS SPECTRUMS | 2006年 / 11卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：253 / 253

页数：1

相关论文

共 50 条

[1] Selegiline Transdermal System In the Treatment of Major Depressive Disorder
James E. Frampton
Greg L. Plosker
Drugs, 2007, 67 : 257 - 265
[2] Selegiline transdermal system: In the treatment of major depressive disorder
Bodkin, J. Alexander
DRUGS, 2007, 67 (02) : 266 - 266
[3] FDA approves duloxetine for the treatment of major depressive disorder
不详
CNS SPECTRUMS, 2004, 9 (09) : 633 - 633
[4] Selegiline transdermal system in major depressive disorder
Patkar, Ashwin A.
Portland, Kimberly B.
Pae, Chi-Un
NEUROPSYCHIATRY, 2012, 2 (02) : 125 - 134
[5] FDA approves duloxetine for maintenance treatment of major depressive disorder
Lanche, Michelisa
CNS SPECTRUMS, 2008, 13 (01) : 23 - 23
[6] FDA approves desvenlafaxine succinate for treatment of major depressive disorder
Cunningham, Jaime
CNS SPECTRUMS, 2008, 13 (05) : 369 - 369
[7] Selegiline transdermal system: a novel treatment option for major depressive disorder
Nandagopal, Jayasree J.
DelBello, Melissa P.
EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (10) : 1665 - 1673
[8] Selegiline transdermal patch (Emsam) for major depressive disorder
Melton, Sarah
Townsend, Charlotte Ann
AMERICAN FAMILY PHYSICIAN, 2008, 77 (04) : 505 - 506
[9] A critical appraisal of the selegiline transdermal system for major depressive disorder
Bied, Adam M.
Kim, Jungjin
Schwartz, Thomas L.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (06) : 673 - 681
[10] Critical appraisal of selegiline transdermal system for major depressive disorder
Cristancho, Mario A.
Thase, Michael E.
EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (05) : 659 - 665

← 1 2 3 4 5 →